probes failed to reveal detectable expression in a panel tion studies using probes labeled with digoxigenin and fluorescein indicated that in neonates, many neurons of 12 different human tissues; however these did not include DRG (not shown).
expressing mrgA3 or mrgA4 coexpress mrgA1 ( Figures  3A-3F , arrowheads). In addition to strongly labeled mrgA4 ϩ cells ( Figure 3E , arrowhead), the fluorescent Different mrgAs Are Expressed in Largely Nonoverlapping Subsets of Sensory Neurons in situ hybridization signals for mrgA4 using tyramide amplification included dots within nuclei that were cirThe in situ hybridization data obtained using individual mrgA probes raised the question of whether these recumscribed by the cytoplasmic expression of mrgA1 mRNA, as detected by fast red ( Figure 3F , arrow). Such ceptors are expressed by distinct or overlapping subsets of sensory neurons. Double-label in situ hybridizadots of mrgA4 expression were not observed using the less sensitive fast red detection method, and were only press mrgA1 in newborn animals. In adults, however, mrgA1 is expressed by a smaller subset of sensory neuobserved in the nuclei of mrgA1 ϩ cells. Similar intranuclear dots have previously been observed in studies rons and only partially overlaps the expression of other mrgAs (see below). of pheromone receptor gene expression, and have been suggested to represent sites of transcription (Pantages To address the question of whether mrgsA2-A8 are expressed in the same or in different neurons, we comand Dulac, 2000). Other mrgA probes gave insufficiently strong signals to be used in such double-labeling experipared the number of neurons labeled by single probes to that labeled by a mixture of all seven probes (Buck and ments. Nevertheless, the results for mrgA1, 3, and 4 suggested that those neurons that express the rarer Axel, 1991). Approximately 3-fold more neurons (4.5% versus 1%) were labeled by the mixed mrgsA2-A8 probe mrgA genes (mrgA2-8) are a subset of those that ex- than by an individual probe (mrgA4; Figures 3J and 3K) , pressed both genes. 34% (118/344) of mrgA1 ϩ cells coexpressed mrgD, while 26.7% (118/442) of mrgD ϩ indicating that these genes are not all coexpressed in the same population of neurons. However, the percentcells coexpressed mrgA1. This partial overlap at birth, however, is transient, and the expression of mrgAs and age of neurons labeled by the mixed probe (4.5%) was less than the sum of the percentage of neurons labeled mrgD becomes segregated in adulthood (see below). A similar pattern of transient coexpression followed by by each of the seven individual probes (6.6%). This observation, and the fact that a higher signal intensity was segregation has been observed for other receptors expressed in subsets of DRG sensory neurons, such as observed in individual neurons using the mixed probe than using a single probe, suggests that there is some trkA and c-ret (Molliver et al., 1997 toward testing this hypothesis, we sought to determine These data suggested that mrgAs and mrgD might be whether these GPCRs could be activated by any known expressed by distinct subsets of IB4 ϩ neurons, which ligands. To this end, we cloned selected mrgA genes, differ quantitatively in their level of c-ret expression.
including mrgA1 and mrgA4, into a eukaryotic expresDouble-labeling experiments with mrgA versus mrgD sion vector and transfected them into human embryonic probes in adult DRGs confirmed that these receptors kidney ( the expression of which reveals an unanticipated degree Thus, MAS1, mrgA1, and mrgA4 expressed in this heterof molecular diversity among DRG sensory neurons. The ologous system are all activated by RFamide family lispecific expression of mrgAs and mrgD in a subset gands, but with differing ligand sensitivities and selectivof IB4 ϩ sensory neurons further suggests that these ities (Table 1) . Importantly, nontransfected HEK-G␣ 15 receptors may be involved in the sensation or modulacells were not activated by any of these RF-amide lition of pain, and could therefore provide targets for antinociceptive drugs. gands ( Figures 6D-6F, open symbols) . 
